Patents by Inventor Iana H. Haralambieva

Iana H. Haralambieva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220112566
    Abstract: This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: RICHARD B. KENNEDY, GREGORY A. POLAND, INNA G. OVSYANNIKOVA, IANA H. HARALAMBIEVA
  • Patent number: 11225691
    Abstract: This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: January 18, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard B. Kennedy, Gregory A. Poland, Inna G. Ovsyannikova, Iana H. Haralambieva
  • Publication number: 20200308659
    Abstract: This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.
    Type: Application
    Filed: June 12, 2020
    Publication date: October 1, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Richard B. Kennedy, Gregory A. Poland, Inna G. Ovsyannikova, Iana H. Haralambieva
  • Patent number: 10683554
    Abstract: This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: June 16, 2020
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard B. Kennedy, Gregory A. Poland, Inna G. Ovsyannikova, Iana H. Haralambieva
  • Publication number: 20180305767
    Abstract: This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.
    Type: Application
    Filed: February 27, 2018
    Publication date: October 25, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Richard B. Kennedy, Gregory A. Poland, Inna G. Ovsyannikova, Iana H. Haralambieva